Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Leontien Kremer

Principal Investigator
--
Phone 088 97 290 000

 --

  • Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines

    • dec. 2022
    • Esmée C., de Baat, et al
    • The Lancet Child and Adolescent Health
  • Childhood cancer survivorship care during the COVID-19 pandemic

    • dec. 2022
    • , et al
    • Journal of Cancer Survivorship
  • Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries

    • nov. 2022
    • Rebecca J., Van Kalsbeek, et al
    • BMJ Open
  • SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

    • nov. 2022
    • Evelien G.E., Hurkmans, et al
    • Frontiers in Pharmacology
  • Cohort profile

    • nov. 2022
    • Yuehan, Wang, et al
    • BMJ Open
View all publications